Objectives:
1. Understand the molecular pathophysiological mechanisms underlying diastolic dysfunction.
2. Learn how Rho kinase (ROCK) can influence cardiac remodeling.
3. Appreciate the therapeutic role of ROCK inhibitors in HFpEF.
Session date:
03/02/2018 - 12:00pm to 1:00pm CST
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
James K. Liao, MD